Assessing the Role of Exercise Intensity in Slowing Disease Progression in Early Parkinson’s Disease

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2006 by Austin Health.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Austin Health
ClinicalTrials.gov Identifier:
NCT00385073
First received: October 5, 2006
Last updated: NA
Last verified: October 2006
History: No changes posted
  Purpose

Participants will complete a self-selected intensity of exercising over a 6 month period, with detailed clinical assessments at commencement and completion to determine the rate of progression of parkinsonism and gait abnormalities


Condition
Parkinson's Disease

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Longitudinal
Official Title: Assessing the Role of Exercise Intensity in Slowing Disease Progression in Early Parkinson’s Disease

Resource links provided by NLM:


Further study details as provided by Austin Health:

Estimated Enrollment: 30
Study Start Date: April 2005
Estimated Study Completion Date: December 2007
Detailed Description:

Participants will complete a self-selected intensity of exercising over a 6 month period - including jogging, swimming and circuit training, with detailed clinical assessments at commencement and completion (including UPDRS, gaitrite lab study) to determine the rate of progression of parkinsonism and gait abnormalities

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Early Parkinson's Disease,
  • Able to provide informed consent,
  • able to complete exercise diaries for 6 months,
  • no medications or on levo-dopa

Exclusion Criteria:

  • Not on dopamine agonists,
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00385073

Contacts
Contact: mary m Galea, PhD 0061383444171 ext nil m.galea@unimelb.edu.au

Locations
Australia
Royal Talbot Rehabilitation Centre Recruiting
Melbourne, Australia
Principal Investigator: mary galea, PhD         
Sponsors and Collaborators
Austin Health
Investigators
Principal Investigator: mary m galea, PgD Austin Health
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00385073     History of Changes
Other Study ID Numbers: 126/05
Study First Received: October 5, 2006
Last Updated: October 5, 2006
Health Authority: Australia: Human Research Ethics Committee

Additional relevant MeSH terms:
Disease Progression
Parkinson Disease
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Disease Attributes
Movement Disorders
Nervous System Diseases
Neurodegenerative Diseases
Parkinsonian Disorders
Pathologic Processes

ClinicalTrials.gov processed this record on October 23, 2014